F.S. Kenny

Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.

F.S. Kenny, Rina Hui, Elizabeth A. Musgrove et al. · PubMed · 1999 · 217 citations · Full text

Medicine, Molecular Biology, Oncology +14

Gamma linolenic acid with tamoxifen as primary therapy in breast cancer

F.S. Kenny, Sarah E. Pinder, Ian O. Ellis et al. · International Journal of Cancer · 2000 · 107 citations · Full text

Medicine, Oncology, Pharmacology +16

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Petra Seibold, Adam Webb, Miguel E. Aguado‐Barrera et al. · Radiotherapy and Oncology · 2019 · 96 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study

Rajiv Dave, Baek Kim, Alona Courtney et al. · British Journal of Cancer · 2021 · 92 citations · Full text

Medicine, Oncology, Surgery +9

EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival

Rina Hui, Jonathon Ball, R. Douglas Macmillan et al. · Oncogene · 1998 · 88 citations

Life Sciences, Genetics, Molecular Biology +14